Madrona Venture Group leads Series A round for A-Alpha Bio
A-Alpha Bio, a biotechnology company, has secured $20 million in Series A financing.
A-Alpha Bio, a biotechnology company, has secured $20 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination